Many Becton, Dickinson and Company(BDX) Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock. Becton Dickinson and Co was Downgraded by Raymond James to Outperform on Jan 5, 2017. Becton Dickinson and Co was Downgraded by JP Morgan to Neutral on Jan 3, 2017.
Company has reported several Insider transactions to the SEC, on Dec 16, 2016, John E Gallagher (VP, Corp Finance and Treasurer) sold 1,793 shares at 168.82 per share price.On Dec 6, 2016, Stephen Sichak (Executive Vice President) sold 2,632 shares at 164.44 per share price.On Sep 7, 2016, Linda M Tharby (Executive Vice President) sold 11,704 shares at 177.34 per share price.
Becton Dickinson and Co Last issued its quarterly earnings results on Feb 2, 2017. The company reported $2.33 EPS for the quarter, beating the analyst consensus estimate by $ 0.21. Analyst had a consensus of $2.12. The company had revenue of $2922.00 million for the quarter, compared to analysts expectations of $2860.52 million. The companys revenue was down -2.1 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $1.96 EPS.
Becton, Dickinson and Company (NYSE:BDX) has received a short term rating of hold from experts at Zacks with a rank of 3. The stock has been rated an average of 1.79 by 14 Brokerage Firm. 8 Wall Street Firms have rated the stock as a strong buys. 1 stock experts have also suggested a buy rating. 5 Brokerage Firms have advised hold.
Becton, Dickinson and Company (NYSE:BDX): 13 Analyst have given the stock of Becton, Dickinson and Company (NYSE:BDX) a near short term price target of $189.54. The standard deviation reading, which is a measure by which the stock price is expected to swing away from the mean estimate, is at $9.51. The higher price target estimate is at $200 while the lower price estimates are fixed at $169.
Becton, Dickinson and Company (NYSE:BDX) rose 0.12% or 0.22 points on Tuesday and made its way into the gainers of the day. After trading began at $178.44 the stock was seen hitting $179 as a peak level and $177.72 as the lowest level. The stock ended up at $178.77. The daily volume was measured at 655,829 shares. The 52-week high of the share price is $181.755 and the 52-week low is $139.81. The company has a market cap of $38,047 million.
Becton, Dickinson and Co. is engaged principally in the manufacture and sale of a broad line of supplies, devices and systems used by health care professionals, medical research institutions and the general public. BDs operations consist of three worldwide business segments: Medical Systems, Biosciences, and Preanalytical Solutions.